ArticleBreast cancer research and treatment2022

Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen.

Brittany Bychkovsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.